Sharemaestro company-news research for BlackRock Health Sciences Trust II (BMEZ), showing current tone, evidence confidence, direct company coverage, sector and industry context, completed price response and the source headlines used on the page. Scores describe published news evidence. Confidence describes the amount, freshness, source breadth and direct company relevance of that evidence. Price context is shown separately.

NYSE United States Insufficient evidence

Company news sentiment

Latest BMEZ news and sentiment

BlackRock Health Sciences Trust II

Company headlines from the last 30 days, weighted by freshness, relevance, publisher quality and the strength of the wording. Price is shown separately.

Latest weekly closeUSD 16.81week of 25 Sep 2026
Main news subjectMarket update82/100 share of current news
News data statusPartial1 duplicate stories removed

Current company news

No current company-news score

No company-specific headline in the last 30 days currently passes the date and relevance checks. The dash means no score; it is not a neutral observation.

Observed headline tone50/100 Published 30-day score50/100

Older, less relevant and less reliable stories count for less. Confidence is shown separately.

Latest source headline BlackRock Health Sciences Trust (NYSE: BME) director reports no holdings in initial insider filing Stock Titan ยท 17 Sep 2026 21:04

Available information

Direct evidence

7 current stories are mapped specifically to BMEZ.

Why there is no score

Too little evidence

The stories agree, but freshness-weighted evidence is only 0.000.

Confidence

Confidence is 0/100, below the threshold for a firm score.

โ€”/100
News scoreNo qualifying directional evidence
0/100
Confidencethin evidence
0%/100
Company news7 company stories
100/100
Story agreement0/100 difference

News history

Daily score and story count over 30 days

Daily weighted evidence ยท gaps mean no reading
30 Aug: 1 stories31 Aug: 3 stories04 Sep: 1 stories09 Sep: 1 stories17 Sep: 1 stories 30 Aug: tone 50, 1 stories31 Aug: tone 50, 3 stories04 Sep: tone 50, 1 stories09 Sep: tone 50, 1 stories17 Sep: tone 50, 1 stories 100500
30 Aug14 Sep28 Sep
News scoreStory count50 baseline

Confidence

How reliable the score is

Separate from direction

Confidence uses the amount of news, separate publishers, direct company relevance, freshness and agreement. A high or low score is not automatically reliable.

Amount of evidence0
0.0 after freshness weighting
Source breadth0
0 independent publishers
Company relevance0
share tied directly to this company
Freshness14
recency-weighted evidence
Agreement100
how closely stories agree
Publisher mix0
less reliance on one publisher

Price and news history

Weekly price and news-score history

No current news signal

No sufficiently fresh, directly relevant company news is available for a price comparison.

26 completed price weeks14 comparable news-score weeks
One scoring method across the chart.Stored company headlines are recalculated at each weekly point with the current 30-day freshness weighting. Old published snapshots are left unchanged.
03 Apr 2026: close 14.034352, indexed 100.010 Apr 2026: close 14.044125, indexed 100.117 Apr 2026: close 14.405587, indexed 102.624 Apr 2026: close 13.873871, indexed 98.901 May 2026: close 13.864024, indexed 98.808 May 2026: close 13.96249, indexed 99.515 May 2026: close 13.745865, indexed 97.922 May 2026: close 14.073383, indexed 100.329 May 2026: close 14.579549, indexed 103.905 Jun 2026: close 14.222256, indexed 101.312 Jun 2026: close 14.327197, indexed 102.119 Jun 2026: close 14.445665, indexed 102.926 Jun 2026: close 15.021506, indexed 107.003 Jul 2026: close 15.597347, indexed 111.110 Jul 2026: close 15.26438, indexed 108.817 Jul 2026: close 15.166058, indexed 108.124 Jul 2026: close 15.205786, indexed 108.331 Jul 2026: close 15.374629, indexed 109.507 Aug 2026: close 15.861293, indexed 113.014 Aug 2026: close 15.940613, indexed 113.621 Aug 2026: close 16.923866, indexed 120.628 Aug 2026: close 16.665638, indexed 118.704 Sep 2026: close 16.854343, indexed 120.111 Sep 2026: close 16.337887, indexed 116.418 Sep 2026: close 16.5, indexed 117.625 Sep 2026: close 16.81, indexed 119.8 26 Jun 2026: news score 50, close 15.021506, 1 stories5003 Jul 2026: news score 50, close 15.597347, 3 stories10 Jul 2026: news score 50, close 15.26438, 3 stories5017 Jul 2026: news score 50, close 15.166058, 7 stories24 Jul 2026: news score 52, close 15.205786, 8 stories5231 Jul 2026: news score 54, close 15.374629, 10 stories07 Aug 2026: news score 52, close 15.861293, 13 stories5214 Aug 2026: news score 51, close 15.940613, 12 stories21 Aug 2026: news score 50, close 16.923866, 9 stories5028 Aug 2026: news score 50, close 16.665638, 7 stories04 Sep 2026: news score 49, close 16.854343, 7 stories4911 Sep 2026: news score 50, close 16.337887, 7 stories18 Sep 2026: news score 50, close 16.5, 8 stories5025 Sep 2026: news score 50, close 16.81, 8 stories50 Price index 123.3 109.3 95.2 News score 100 50 0
03 Apr30 Jun25 Sep
Weekly close, indexedSentiment score
26-week price+19.8%latest close 16.81
News score change+0first to latest comparable week
One-week response+1.9%Price digesting
Fair-value position+28.0%Materially above fair value
WeekNews scoreCloseWeekly move
25 Sep 202650USD 16.81+1.9%
18 Sep 202650USD 16.5+1.0%
11 Sep 202650USD 16.337887-3.1%
04 Sep 202649USD 16.854343+1.1%
28 Aug 202650USD 16.665638-1.5%
21 Aug 202650USD 16.923866+6.2%
14 Aug 202651USD 15.940613+0.5%
07 Aug 202652USD 15.861293+3.2%
Insufficient evidence

News subjects

What is shaping the score

Market update
Market update506 stories ยท 86%
Analyst action501 stories ยท 14%

Source mix

Where the evidence comes from

0/100 independence
Value Research503 stories ยท 43%
Stock Traders Daily502 stories ยท 29%
Stock Titan501 stories ยท 14%
www.marketscreener.com501 stories ยท 14%

Recurring subjects

Subjects appearing most often

Current evidence
Financial Markets3Life Sciences2Finance1Earnings1

Earlier readings

How the score has changed

21 comparable readings ยท 95 days
Past and present use the same method.Each point recalculates the previous 30 days of stored company headlines with today's scoring rules. The original stored snapshots remain unchanged.
Comparable move+050 to 50 ยท Broadly stable
Observed range49โ€“5450 is the neutral baseline
Evidence depth7stories at latest stored reading ยท +6
Confidence15/100Provisional ยท +15
24 Jun50 neutral28 Sep 05:07
ConstructiveBalanced or withheldCautious

Changes in the stored score

Scores are rebuilt from stored headlines with the current 30-day method. Days with no change are collapsed.

ObservedScoreMoveConfidenceStoriesStatus
28 Sep 05:0750+015/100 (-1)7 (-1)Provisional
17 Sep 23:5950+016/100 (-5)8 (+1)Provisional
09 Sep 23:5950+121/100 (-8)7 (0)Provisional
04 Sep 23:5949-129/100 (+15)7 (-3)Provisional
31 Aug 23:5950+014/100 (0)10 (+3)Provisional
30 Aug 23:5950+014/100 (0)7 (0)Provisional
27 Aug 23:5950-114/100 (-5)7 (-7)Provisional
09 Aug 23:5951-219/100 (-6)14 (+1)Provisional

Evidence behind the direction

What drives this reading?

0 directional stories ยท 0 publisher groups

Shares of weighted directional evidence in 7 retained current headlines. These weights already account for freshness, relevance and publisher limits; they are not additive points of the published score.

No directional evidence to attribute yet

Company news can still be read below. Influence bars appear when a current story qualifies for the directional score.

Source headlines

The news behind the score

Showing 1-7 of 7

Only company-specific stories enter this score. The latest 30 days are shown newest first, with newer stories weighted more heavily and duplicate coverage combined.

Company news retained for context; no directional weight.
Scoring detailsDirect company coverage
Published
17 Sep 2026 21:04
News subject
Market update
Why this score
No clear directional signal in the available text
Company focus
Main company ยท 100%
How it is used
Shown as company news ยท not used in the score
Story strength
Not directional
30-day weight
None ยท 10.6d old
Text assessed
Stored headline only
Duplicates
1 consolidated
—Unscored

This article provides an analysis of Blackrock Health Sciences Term Trust (NASDAQ: BMEZ), highlighting a neutral sentiment across all time horizons. It suggests a "wait-and-see" approach and outlines three distinct institutional trading strategies: Position Trading, Momentum Breakout, andโ€ฆ

Company news retained for context; no directional weight.
Scoring detailsDirect company coverage

This article provides an analysis of Blackrock Health Sciences Term Trust (NASDAQ: BMEZ), highlighting a neutral sentiment across all time horizons. It suggests a "wait-and-see" approach and outlines three distinct institutional trading strategies: Position Trading, Momentum Breakout, and Risk Hedging, along with AI-generated signals for support and resistance levels.

Published
09 Sep 2026 19:44
News subject
Market update
Why this score
No clear directional signal in the available text
Company focus
Main company ยท 100%
How it is used
Shown as company news ยท not used in the score
Story strength
Not directional
30-day weight
None ยท 18.7d old
Text assessed
Stored article
Duplicates
1 consolidated
Financial MarketsLife Sciences
Company news retained for context; no directional weight.
Scoring detailsDirect company coverage
Published
04 Sep 2026 07:00
News subject
Market update
Why this score
Negative financial language
Company focus
Main company ยท 100%
How it is used
Shown as company news ยท not used in the score
Story strength
Not directional
30-day weight
None ยท 24.2d old
Text assessed
Stored headline only
Duplicates
1 consolidated
Company news retained for context; no directional weight.
Scoring detailsDirect company coverage
Published
31 Aug 2026 21:30
News subject
Market update
Why this score
No clear directional signal in the available text
Company focus
Main company ยท 100%
How it is used
Shown as company news ยท not used in the score
Story strength
Not directional
30-day weight
None ยท 27.6d old
Text assessed
Available headline and article text
Duplicates
1 consolidated
Company news retained for context; no directional weight.
Scoring detailsDirect company coverage
Published
31 Aug 2026 16:48
News subject
Market update
Why this score
No clear directional signal in the available text
Company focus
Main company ยท 100%
How it is used
Shown as company news ยท not used in the score
Story strength
Not directional
30-day weight
None ยท 27.8d old
Text assessed
Stored headline only
Duplicates
1 consolidated

BlackRock has announced the estimated sources of distributions for several of its closed-end funds, paid on August 31, 2026. These funds utilize a managed distribution plan, potentially including net income, capital gains, or return of capital to maintain level monthly payouts. The announโ€ฆ

Company news retained for context; no directional weight.
Scoring detailsDirect company coverage

BlackRock has announced the estimated sources of distributions for several of its closed-end funds, paid on August 31, 2026. These funds utilize a managed distribution plan, potentially including net income, capital gains, or return of capital to maintain level monthly payouts. The announcement includes detailed breakdowns of distribution sources for individual funds for both the August payment and the fiscal year to date, along with performance and distribution rate information.

Published
31 Aug 2026 16:32
News subject
Market update
Why this score
Positive financial language
Company focus
Main company ยท 100%
How it is used
Shown as company news ยท not used in the score
Story strength
Not directional
30-day weight
None ยท 27.8d old
Text assessed
Stored article
Duplicates
1 consolidated
EarningsFinanceFinancial Markets
—Unscored

This article provides an AI-generated analysis for Blackrock Health Sciences Term Trust Of Beneficial Interest (NASDAQ: BMEZ), highlighting neutral near-term readings and potentially stalling mid-term strong sentiment. It outlines institutional trading strategies including long, breakout,โ€ฆ

Company news retained for context; no directional weight.
Scoring detailsDirect company coverage

This article provides an AI-generated analysis for Blackrock Health Sciences Term Trust Of Beneficial Interest (NASDAQ: BMEZ), highlighting neutral near-term readings and potentially stalling mid-term strong sentiment. It outlines institutional trading strategies including long, breakout, and short positions with specific entry, target, and stop-loss levels. The analysis also includes multi-timeframe signal analysis indicating support and resistance levels.

Published
30 Aug 2026 10:26
News subject
Analyst action
Why this score
Positive financial language
Company focus
Main company ยท 100%
How it is used
Shown as company news ยท not used in the score
Story strength
Not directional
30-day weight
None ยท 29.1d old
Text assessed
Stored article
Duplicates
1 consolidated
Financial MarketsLife Sciences

Earlier company news

BMEZ news archive

16 older headlines

Stored newest first for historical research. It starts after the newest three pages above and then continues through older news. Each archive page is loaded only when it is opened.

Older news is kept in the archive

There are 16 older BMEZ headlines. Open one page at a time when you need them.

Open older archive

Provider matches checked

Provider mentions not used in the score

6 not scored

A news provider linked these stories to BMEZ, but the headline and available text are not mainly about BlackRock Health Sciences Trust II. They are kept here for transparency and do not affect the score, confidence, history or wider market totals.

Provider mentions are kept separate

Open the list to see which provider matches were checked and left out of BMEZ sentiment.

Open provider mentions

How the page works

How to read the score

The score shows direction

It describes the weighted balance of qualifying headlines. A score of 50 can mean balanced news or that there is not enough evidence; the status label explains which.

Confidence is separate

Confidence measures depth, source breadth, direct relevance, freshness and agreement. It does not rise merely because the tone is extreme. This is a rule-based evidence measure, not a calibrated probability.

Price is confirmation

Weekly price response, trend and fair-value position test whether the market is accepting or rejecting the news. They never rewrite the news score.

What the page does

It measures news already published. It is not a forecast, recommendation or price target.

Evidence context